The medical device producer has now raised $40m in financing altogether, having secured $4m in a Novo-backed equity round and $4m in debt from GE Capital.

US-based medical device maker Cianna Medical raised $8m in equity and debt from investors including pharmaceutical company Novo’s corporate venturing unit, Novo Ventures.

Fog City Fund, Saints Capital and Emergent Medical Partners contributed to the $4m equity portion of the round alongside Novo. GE Capital, the financial services subsidiary of conglomerate General Electric, concurrently provided $4m in debt financing for Cianna.

Founded in 2007, Cianna has developed a range of products under its Savi brand to treat breast cancer. Savi…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?